T1	Treatment 11 55	formoterol, salmeterol or oxitropium bromide
T2	Treatment 79 89	salbutamol
T3	Treatment 140 185	formoterol, oxitropium bromide, or salmeterol
T4	Treatment 235 245	salbutamol
T5	Treatment 400 524	received 24 microg formoterol, 50 microg salmeterol, 200 microg oxitropium bromide, or placebo on four non-consecutive days.
T6	Treatment 525 544	Spirometric testing
T7	Treatment 650 660	salbutamol
T8	Treatment 670 781	constructed using doses of 100, 100, 200 microg and 400 microg--that is, a total cumulative dose of 800 microg.
T9	Treatment 882 904	Formoterol, salmeterol
T10	Treatment 909 927	oxitropium bromide
T11	Treatment 1023 1030	placebo
T12	Treatment 1055 1062	placebo
T13	Treatment 1069 1079	formoterol
T14	Treatment 1086 1096	salmeterol
T15	Treatment 1103 1121	oxitropium bromide
T16	Treatment 1270 1278	placebo:
T17	Treatment 1309 1320	formoterol:
T18	Treatment 1351 1362	salmeterol:
T19	Treatment 1393 1412	oxitropium bromide:
T20	Treatment 1584 1629	formoterol, salmeterol, or oxitropium bromide
T21	Treatment 1644 1652	placebo.
T22	Treatment 1726 1771	formoterol, salmeterol, or oxitropium bromide
T23	Treatment 1849 1859	salbutamol
